Handelsbanken has initiated coverage of Bioarctic, issuing a buy recommendation and setting a target price of SEK 355.
The bank's analysts believe that Bioarctic presents strong growth potential, justifying their positive outlook on the company's shares. The target price reflects Handelsbanken's confidence in Bioarctic's future prospects.

















